Biophage Pharma Inc. (TSX: BUG.V), a leading innovator of biosensor devices based on nanotechnology and aimed at live pathogen diagnostics, announced today it has obtained an advance income tax ruling from the ministère du Revenu du Québec confirming that the common shares of Biophage could be included on the list drawn up by the Autorité des marchés financiers (“AMF”) and be valid shares for the SME Growth Stock Plan, in accordance with the measures contained in the 2005-2006 Québec budget tabled on April 21, 2005. In this regard, an application for registration has already been filed before the AMF and the common shares of Biophage will be included on the AMF list shortly.
